Parallel session 10:00 - 12:00
Complex drug products: new insights in development and production
This session will continue in the afternoon with the session: Regulatory innovation: advancing complex drug product approval
Recent developments in innovative technologies like Advanced Therapy Medicinal Products (ATMPs) and Nano-medicines provide new opportunities to address the increasing demands of an aging population, as well as for diseases with high unmet medical needs.
Despite recent innovations and considerable research and development efforts there is clear mismatch between these research and development efforts and the number of approved products in the European Union. The road from development to approval poses many challenges for scientists, developers and regulators and asks for collaborative opportunities to meet those challenges, which we will discuss in two sessions.
Speakers will be announced shortly